Moving forward one notch at a time

Journal of Clinical Oncology

Volumn 30, Issue 19, 2012, Pages 2291-2293

  Gounder, Mrinal M ^a   Schwartz, Gary K ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CYCLIN D1; MK 0752; MYC PROTEIN; N (6,7 DIHYDRO 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL) 2,2 DIMETHYL N' (2,2,3,3,3 PENTAFLUOROPROPYL)PROPANEDIAMIDE; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH4 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SURVIVIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALZHEIMER DISEASE; CANCER CHEMOTHERAPY; COUGHING; DIARRHEA; DRUG HALF LIFE; DRUG SAFETY; EDITORIAL; FATIGUE; HUMAN; PHARMACODYNAMICS; PHASE 1 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SOLID TUMOR;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANTINEOPLASTIC AGENTS; BENZAZEPINES; FEMALE; HUMANS; MALE; NEOPLASMS; PROPIONIC ACIDS; RECEPTORS, NOTCH; SULFONES;

EID: 84864007913     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.3277     Document Type: Editorial

References (10)

1. Tolcher AW, Messersmith WA, Mikulski SM, et al: Phase I study of RO4929097, a gamma secretase inhibitor of Notch signaling, in patients with refractory metastatic or locally advanced solid tumors. J Clin Oncol 30:2348-2353, 2012
2. Krop I, Demuth T, Guthrie T, et al: Phase I pharmacologic and pharmacodynamic study of the gamma secretase (Notch) inhibitor MK-0752 in adult patients with advanced solid tumors. J Clin Oncol 30:2307-2313, 2012
3. Bolós V, Grego-Bessa J, de la Pompa JL: Notch signaling in development and cancer. Endocr Rev 28:339-363, 2007 (Pubitemid 46984831)
4. Bray SJ: Notch signalling: A simple pathway becomes complex. Nat Rev Mol Cell Biol 7:678-689, 2006
5. Takebe N, Harris PJ, Warren RQ, et al: Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nature 8:97-106, 2011
6. Groth C, Fortini ME: Therapeutic approaches to modulating Notch signaling: Current challenges and future prospect. Semin Cell Dev Biol [epub ahead of print on January 30, 2012]
7. DeAngelo DJ, Stone RM, Silverman LB, et al: A phase I clinical trial of the notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia/ lymphoma (T-ALL) and other leukemias. J Clin Oncol 24:357s, 2006 (suppl 15; abstr 6585)
8. Palomero T, Dominguez M, Ferrando AA: The role of the PTEN/AKT pathway in notch1-induced leukemia. Cell Cycle 7:965-970, 2008 (Pubitemid 351679827)
9. Blackman SC, Klappenbach JA, Railkar RA, et al: Identification of a time-and dose-responsive transcriptional signature of Notch pathway inhibition in plucked human hair follicles following exposure to the gamma-secretase inhibitor MK-0752. Mol Cancer Ther 8, 2009 (suppl 1; abstr B41)
10. Fouladi M, Stewart CF, Olson J, et al: Phase I trial of MK-0752 in children with refractory CNS malignancies: A pediatric brain tumor consortium study. J Clin Oncol 29:3529-3534, 2011